With President-elect Donald Trump proposing tariffs as high as 60%- 100% on goods imported from China, Wall Street analysts ...

As birth rates increase across both developed and developing countries, coupled with the rising incidence of paediatric ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

The global non-invasive respiratory monitoring market is poised for substantial growth, projected to increase from an estimated valuation of USD 8.4 Billion in 2023 to USD 15.0 Billion by 2033, at a ...